Journal: Molecular neurobiology
Article Title: Recombinant FGF21 protects against blood-brain barrier leakage through Nrf2 upregulation in type 2 diabetes mice
doi: 10.1007/s12035-018-1234-2
Figure Lengend Snippet: Cultured HBMEC monolayer treated with HG-IL1β was used to mimic BBB injury under diabetic conditions. The monolayer was then treated with rFGF21 and the permeability was measured. (A) IL-1β protein level in diabetic mice brain measured by Western blot (* p<0.05 vs. db/+, n=4); (B) Viability of cultured HBMEC after treatment with HG-IL1β and rFGF21; (C) Relative HBMEC monolayer permeability after treatment with HG-IL1β and rFGF21 (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (D) Representative western blot images of junction protein expression in cultured HBMEC after HG-IL1β and rFGF21 treatment; (E, F, G) Quantification of junction protein ZO-1, VE-cadherin and Occludin in cultured HBMEC (*p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (H) Immunocytochemistry of ZO-1 and VE-cadherin in cultured HBMEC after HG-IL1β and rFGF21 treatment.
Article Snippet: Primary HBMEC was obtained from Cell Systems Corporation (ACBRI376, Kirkland, WA), and cultured in complete growth media EBM-2 containing supplements growth factors (Lonza, Walkersville, MD).
Techniques: Cell Culture, Permeability, Western Blot, Expressing, Immunocytochemistry